menu
    • menu

    Company profile for Anika Therapeutics

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anika is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain managem...
    Anika is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Anika TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    32 Wiggins Avenue Bedford, MA 01730
    Telephone
    Telephone
    +1-781-457-9000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://anika.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anika To Present At Canaccord Genuity Musculoskeletal Conference
    Anika To Present At Canaccord Genuity Musculoskeletal Conference

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240602/28467/en/Anika-To-Present-at-the-Canaccord-Genuity-2026-Musculoskeletal-Conference.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Anika To Release Q4 And 2025 Financial Results On Feb 26, 2026
    Anika To Release Q4 And 2025 Financial Results On Feb 26, 2026

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237637/28467/en/Anika-to-Issue-Fourth-Quarter-and-Year-End-2025-Financial-Results-on-Thursday-February-26-2026.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Anika Therapeutics Announces Leadership Transition
    Anika Therapeutics Announces Leadership Transition

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215223/28467/en/Anika-Therapeutics-Announces-Leadership-Transition.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Anika Reports Third Quarter 2025 Financial Results
    Anika Reports Third Quarter 2025 Financial Results

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181322/28467/en/Anika-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Anika Therapeutics Files Final PMA Module For Hyalofast
    Anika Therapeutics Files Final PMA Module For Hyalofast

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181299/28467/en/Anika-Therapeutics-Reports-Filing-of-Final-PMA-Module-for-Hyalofast-Cartilage-Repair-Scaffold-and-Data-from-U-S-Pivotal-FastTRACK-Phase-III-Study.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Anika To Release Q3 2025 Financial Results On Nov 5, 2025
    Anika To Release Q3 2025 Financial Results On Nov 5, 2025

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3172422/28467/en/Anika-to-Issue-Third-Quarter-2025-Financial-Results-on-Wednesday-November-5-2025.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search